About this trial
Fibromyalgia (FM) is a prevalent chronic pain disorder, characterized by widespread musculoskeletal pain and fatigue that is associated with significant functional limitations. Its mechanisms are only partially understood. The investigators hypothesize that physical functioning (as measured by the 6-Min Walk Test) of FM patients and healthy controls is negatively influenced by resilience and pain sensitivity. The investigators will perform a case control study to test our hypothesis within and between groups.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Ages 18-70
Fulfills the 1990 and 2011 American College of Rheumatology Criteria for FM
Healthy volunteers: No significant pain
Disqualifiers
Uncontrolled diabetes
Cancer
Uncontrolled coronary syndromes
Peripheral neuropathies
Trial population
This is a case-control study of FM and healthy controls (HC) that will be enrolled in a ratio of 1:1. Healthy controls will be age/gender matched to the FM group.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Resilience score
The Brief Resilience Scale (BRS) is a self-report measure designed to assess an individual's ability to bounce back or recover from stress, adversity, and challenging life circumstances (Smith et al., 2008) scored ranging 6-30.
Performance in 6MWT
The total walking distance in the 6MWT is a measurement of how far an individual is able to walk (measured in meters, using a marked 30m hallway) within a 6 minute time period after being instructed to walk as far possible.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: